.jpg?format=webp&width=780)
European and Australian cystic fibrosis (CF) reproductive carrier screening guidelines recommend testing a small number of high-frequency CF causing variants rather than comprehensive CFTR sequencing. The study objective was to determine variant detection rates of commercially available targeted reproductive carrier screening tests in Australia. Variant detection rates of the tests for 50 and 175 CF causing variants were 88.2% and 90.8%, respectively. Reproductive carrier screening tests for a targeted set of high-frequency CF variants cannot detect approximately 10% of CF variants in a multiethnic Australian population. Individuals of East Asian ethnicity are disproportionally affected by this test limitation.
Like
Save
Share